Yrjana, Kaisa R.Keevil, Victoria L.Soiza, Roy LLuben, Robert N.Wareham, Nicholas J.Khaw, Kay-TeeMyint, Phyo K.2020-07-312020-07-312020-12-01Yrjana, K R, Keevil, V L, Soiza, R L, Luben, R N, Wareham, N J, Khaw, K-T & Myint, P K 2020, 'Anticholinergic medication exposure predicts poor physical capability : Findings from a large prospective cohort study in England.', Maturitas, vol. 142, pp. 55-63. https://doi.org/10.1016/j.maturitas.2020.07.0060378-5122ORCID: /0000-0003-3852-6158/work/163198685https://hdl.handle.net/2164/14822Funding: The EPIC-Norfolk study has been supported by grants from Medical Research Council [grant numbers G9502233, G0401527] and Cancer Research UK [grant number C864/A8257]; and the third health examination clinic was supported by a grant from Research into Ageing [grant number 262]. The funders have had no roles in the study design or interpretation of the results. VLK is supported by a MRC/NIHR Clinical Academic Research Partnership Grant. KRY is currently employed as a regulatory affairs student assistant at Lundbeck (Ottiliavej 9, 2500 Copenhagen, Denmark) Acknowledgements: We would like to thank the participants of the EPIC-Norfolk study as well as the participating general practitioners and administrative and research staff who made the study possible.9273556engSDG 3 - Good Health and Well-beingPhysical capabilityAnticholinergic burdenOlder peopleR MedicineGeneral Biochemistry,Genetics and Molecular BiologyObstetrics and GynaecologyMedical Research Council (MRC)G9502233G0401527Cancer Research UKC864/A8257Other262]National Institute for Health Research (NIHR)RJournal article10.1016/j.maturitas.2020.07.006http://www.scopus.com/inward/record.url?scp=85088784192&partnerID=8YFLogxK142